Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2026 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de serviceAcceptable Use
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to Reports
MedTech

ForSight Robotics

ForSight Robotics raises $125M Series B at $700M valuation

Menlo Park, CAJune 12, 20251 min read
Total Raised
$125M
Valuation
$700M
Latest Round
Series B
Employees
200+

ForSight Robotics: Series B Funding Round

ForSight Robotics has successfully raised $125M in Series B funding, reaching a valuation of $700M.

Company Overview

Ophthalmic surgical robots

Funding Details

The Series B round was led by Eclipse Ventures, with participation from Vensana Capital.

Company Information

  • Headquarters: Menlo Park, CA
  • Founded: 2018
  • Employees: 200+
  • Category: MedTech

Investment

ForSight Robotics plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Eclipse Ventures: Verified investor in Series B
  • Vensana Capital: Verified investor in Series B

Company Info

Headquarters
Menlo Park, CA
Founded
2018
Team Size
200+
Last Round
$125M(Jun 2025)

Investors (2)

E
Eclipse VenturesLead
Lead Investor
Verified investor in Series B
V
Vensana Capital
Investor
Verified investor in Series B

Topics

verified(3079)real-funding(3079)series-b(280)forsight-roboticsmedtechmenlo-park

Share

Related Reports

MedTech
Galvenize Therapeutics

Galvenize Therapeutics Raises $100M Series C to Transform MedTech

Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...

David Chen
David Chen
Oct 22, 2025
0 min read•$100M Series C
MedTech
Reprieve Cardiovascular

Reprieve Cardiovascular Raises $61M Series B to Transform MedTech

Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...

David Chen
David Chen
Oct 22, 2025
0 min read•$61M Series B
MedTech
ViCentra

ViCentra Raises $85M Series D to Transform MedTech

ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...

Sarah Kim
Sarah Kim
Oct 22, 2025
0 min read•$85M Series D

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free